Over 94% of colorectal cancer cells have mutations in one or more members of the Wnt signaling pathway [5], of which 80% of sporadic colorectal cancers are associated with mutation of APC and 10% with mutation of CTNNB1, the gene encoding the protein of β-catenin [4]. This evidence concerns the gene CTNNB1 and colorectal cancer.